Research Article

Comparative Gene Expression Profiling of Benign and Malignant Lesions Reveals Candidate Therapeutic Compounds for Leiomyosarcoma

Figure 5

In vitro cell viability of LMS cell lines treated with bortezomib. LMS03, LMS04, and LMS05 were exposed to bortezomib at concentrations ranging from 0 to10  M. Cell viability was assessed 72 h after exposure to drugs using WST-1 assays and experiments were performed in triplicate.
805614.fig.005